We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 12,246 | 14:00:11 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
Hot Features
Premium
RNS Number:4092S
Celsis International PLC
06 March 2007
Celsis International Plc
(the "Company")
Notification of Major Interests in Shares
6 March 2007: Celsis International Plc was notified on 5 March 2007 by Fidelity
Investments International that, as at 1 March 2007, two legal entities, Fidelity
International Limited ("FIL") and FMR Corp ("FMR"), were subject to notification
obligations in respect of the Company.
Prior to the implementation of the EU Transparency Directive, Fidelity
Investments International aggregated the interests in shares of FMR and FIL
together for the purposes of shareholder reporting. According to the new DTR
rules, Fidelity Investments International is now reporting the indirect holdings
of FMR and FIL separately.
As at 1 March 2007, FMR holds 680,248 ordinary shares in the Company, which
represents approximately 3.08 percent of the issued share capital and voting
rights of the Company.
As at 1 March 2007, FIL holds 39,900 ordinary shares in the Company, which
represents approximately 0.18 percent of the issued share capital and voting
rights of the Company.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUNRURBVRORAR
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
